Empagliflozin suppresses mitochondrial reactive oxygen species generation and mitigates the inducibility of atrial fibrillation in diabetic rats

INTRODUCTION: Recent studies have demonstrated that sodium-glucose co-transporter-2 inhibitors (SGLT2-i) reduce the risk of atrial fibrillation (AF) in patients with diabetes mellitus (DM), in which oxidative stress due to increased reactive oxygen species (ROS) contributes to the pathogenesis of AF...

Descripción completa

Detalles Bibliográficos
Autores principales: Koizumi, Takuya, Watanabe, Masaya, Yokota, Takashi, Tsuda, Masumi, Handa, Haruka, Koya, Jiro, Nishino, Kotaro, Tatsuta, Daishiro, Natsui, Hiroyuki, Kadosaka, Takahide, Koya, Taro, Nakao, Motoki, Hagiwara, Hikaru, Kamada, Rui, Temma, Taro, Tanaka, Shinya, Anzai, Toshihisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9940756/
https://www.ncbi.nlm.nih.gov/pubmed/36815024
http://dx.doi.org/10.3389/fcvm.2023.1005408

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9940756/
https://www.ncbi.nlm.nih.gov/pubmed/36815024
http://dx.doi.org/10.3389/fcvm.2023.1005408

Ejemplares similares